Dr. Christopher Alexander Jimenez, MD

Dr. Jimenez practices at Neuroscience Consultants in South Miami, Florida.

Dr. Jimenez's NPI, 1730509068, was assigned on April 25, 2014. Dr. Jimenez graduated from University of Miami, Miller School of Medicine in 2014. Dr. Jimenez holds Florida license ME136278.

Dr. Jimenez's primary practice is Neuroscience Consultants, at 7000 Sw 62nd Ave, South Miami, FL 33143 in Miami-Dade County. The practice phone is (786) 924-1311.

Dr. Jimenez's primary practice is Neuroscience Consultants in South Miami, Florida. Dr. Jimenez is also affiliated with Baptist Health Baptist Hospital. The medical group on file is First Choice Neurology. Dmand AI also links Dr. Jimenez to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jimenez practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Jimenez's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Jimenez is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dr. Jimenez is licensed in Florida.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, head injury and lower back pain among the conditions Dr. Jimenez treats.

CMS data shows 814 Medicare services from Dr. Jimenez across 13 procedure codes in 2024, for 356 Medicare patients. Medicare paid $101,627 for them.

CMS counts 356 Medicare patients who saw Dr. Jimenez in 2024. The largest group is 75 to 84, with 146 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jimenez's median patient age at 69, with 62% women.

In 2024, Dr. Jimenez wrote 2,674 Medicare Part D claims for 533 patients. 90% of them were for generic drugs. CMS names the drug for 2,378 of them, across 50 drugs with 11 or more claims each, at $1,320,140 in total drug cost. In 2023, CMS named 1,677 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Jimenez for performance year 2024, reported individually. Dr. Jimenez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jimenez as offering telehealth. CMS counts 20 procedures of skin biopsy by Dr. Jimenez, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Jimenez in 2011. The most frequent topics are Brain. Dr. Jimenez's most frequent co-author is Juan Carlos De Rivero Vaccari, MD, PhD.

CMS Open Payments shows 1,170 general payments to Dr. Jimenez from 66 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $3,142.

Dr. Jimenez graduated from University of Miami, Miller School of Medicine in 2014.

Dr. Jimenez is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.